Immune Design Corp.
IMDZ
IMDZ was delisted on the 1st of April, 2019.
72 hedge funds and large institutions have $80.3M invested in Immune Design Corp. in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 14 closing their positions.
81% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 16
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 76 → 72 (-4)
20% less capital invested
Capital invested by funds: $101M → $80.3M (-$20.6M)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
92% less call options, than puts
Call options by funds: $4K | Put options by funds: $49K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$9.33M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$773K |
| 4 |
TI
Telemetry Investments
New York
|
+$742K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$571K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$12.6M |
| 2 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$5.79M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$1.18M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$1.07M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$613K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MCM
76
Moore Capital Management
New York
| – | -$390K | -100,000 | Closed |
|
|
AFM
77
Anson Funds Management
Dallas,
Texas
| – | -$313K | -80,189 | Closed |
|
78
Squarepoint
New York
| – | -$141K | -36,250 | Closed |
|
|
SIM
79
Spark Investment Management
New York
| – | -$52K | -13,500 | Closed |
|
|
WAM
80
Weiss Asset Management
Boston,
Massachusetts
| – | -$44K | -11,309 | Closed |
|
|
TRCT
81
Tower Research Capital (TRC)
New York
| – | -$21K | -5,333 | Closed |
|
82
Parallax Volatility Advisers
San Francisco,
California
| – | -$19K | -4,914 | Closed |
|
83
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$9K | -2,300 | Closed |
|
84
UBS Group
Zurich,
Switzerland
| – | -$5K | -1,297 | Closed |
|
IMDZ Hedge Fund Activity: Q1 2018 in Review
72 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q1 2018, worth a combined $80.3M — down 20% from $101M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of IMDZ and 11 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 29 added.
The largest buyer was BVF Inc, adding an estimated $9.33M. The largest seller was Franklin Resources, exiting entirely with an estimated $12.6M sold.
- 72 institutional investors held Immune Design Corp. (IMDZ) as of Q1 2018, down from 76 in Q4 2017.
- Funds reported $80.3M of Immune Design Corp. stock for Q1 2018, down 20% quarter-over-quarter.
- 11 funds opened new Immune Design Corp. positions in Q1 2018 and 14 closed out, a net change of -3 holders.
- The largest Immune Design Corp. buyer in Q1 2018 was BVF Inc, an estimated $9.33M added.
- The largest Immune Design Corp. seller in Q1 2018 was Franklin Resources, an estimated $12.6M sold.
Based on aggregated 13F filings for Q1 2018.